SCHEMBL6416293

SCHEMBL6416293

NN=C(c1ccc(-c2ccc(Cl)c(C(=O)O)c2)o1)c1nc2nonc2nc1Nc1ccccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
MAPT P10636 7/20 0.41
POLB P06746 7/20 0.41
KDM4E B2RXH2 6/20 0.41
RPA1 P27694 1/20 0.38
KMT2A Q03164 8/20 0.38
MEN1 O00255 7/20 0.38
PKM P14618 3/20 0.38
MCL1 Q07820 2/20 0.38
USP2 O75604 1/20 0.38
BIRC5 O15392 1/20 0.36
TDP1 Q9NUW8 5/20 0.36
L3MBTL1 Q9Y468 4/20 0.36
GAA P10253 3/20 0.36
RECQL P46063 2/20 0.36
CTDSP1 Q9GZU7 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
NPSR1 Q6W5P4 2/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6418347 0.92 LDHA (0.40) ALDH1A1MAPTPOLBKDM4EKMT2A
SCHEMBL6418358 0.92 LDHA (0.40) ALDH1A1MAPTPOLBKDM4EKMT2A
SCHEMBL6435669 0.89 MAPT (0.44) ALDH1A1MAPTPOLBKDM4EKMT2A
SCHEMBL6435995 0.88 BIRC5 (0.50) ALDH1A1MAPTPOLBKDM4EKMT2A
SCHEMBL6432253 0.87 RPA1 (0.44) ALDH1A1MAPTPOLBKDM4ERPA1
SCHEMBL6433045 0.87 KDM4E (0.45) ALDH1A1MAPTPOLBKDM4ERPA1
SCHEMBL6422204 0.85 KDM4E (0.44) ALDH1A1MAPTPOLBKDM4ERPA1
SCHEMBL6415140 0.85 MAPT (0.42) ALDH1A1MAPTPOLBKDM4EKMT2A
SCHEMBL6414388 0.85 ALDH1A1 (0.43) ALDH1A1MAPTPOLBKDM4ERPA1
SCHEMBL6414398 0.85 ALDH1A1 (0.43) ALDH1A1MAPTPOLBKDM4ERPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143382-A1 Heterocyclic compounds as pharmaceutically active compounds 4SC AG (DE) 2005-06-30 US disclosed
WO-2005044270-A1 OXADIAZOLOPYRAZINE DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS 4SC AG (DE) 2005-05-19 WO disclosed
EP-1529531-A1 Oxadiazolopyrazine derivatives as pharmaceutically active compounds 4SC AG (DE) 2005-05-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143382-A1 Heterocyclic compounds as pharmaceutically active compounds NR5A2, NR1H2, NR2C2 ALDH1A1 1119/4885MAPT 4420/4885POLB 3589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.